What drove the big volume move in B8F.DE stock today?

The surge was volume-driven trading on XETRA with **45,797** shares changing hands. We did not find a single confirming external headline. Small market-cap names can spike from concentrated orders or trading interest rather than firm news.

What are the key valuation metrics for B8F.DE stock?

Key figures: market cap **€20,673,478**, EPS **-0.21**, P/E **-32.40**, price-to-sales **0.64**, and book value per share **€0.31**. These show a loss-making firm with thin absolute market value and mixed valuation signals.

What price target does Meyka AI give B8F.DE stock?

Meyka AI's forecast model projects a 12-month target of **€8.50**, implying **24.97%** upside from **€6.80**. Forecasts are model-based projections and not guarantees; treat them as one input among many.

Is B8F.DE stock suitable for conservative investors?

No. B8F.DE is a small-cap, high-volatility healthcare stock with negative EPS and low liquidity. Conservative portfolios typically avoid such exposure unless position sizes remain tiny and well diversified.

DE Stocks

Biofrontera AG (B8F.DE XETRA) jumps to €6.80 on heavy volume: monitor price targets

ByHuzaifa Zahoor February 6, 2026February 6, 2026

The B8F.DE stock closed at €6.80 on XETRA on 05 Feb 2026 after a sharp intraday rise and high volume of 45,797 shares. The price moved from an open of €0.37 to a day high of €6.80, driven by intense trading in this small-cap healthcare name. With a market cap of €20,673,478 and average daily volume near 605 shares, the spike pushed relative volume to 75.70. We examine what moved Biofrontera AG, how valuation holds up, and near-term scenarios for traders and longer-term holders.